Acid sphingomyelinase deficiency: a clinical and immunological perspective
C Pinto, D Sousa, V Ghilas, A Dardis, M Scarpa… - International Journal of …, 2021 - mdpi.com
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disease caused by
deficient activity of acid sphingomyelinase (ASM) enzyme, leading to the accumulation of …
deficient activity of acid sphingomyelinase (ASM) enzyme, leading to the accumulation of …
The world of rare interstitial lung diseases
K Buschulte, V Cottin, M Wijsenbeek… - European …, 2023 - Eur Respiratory Soc
The world of rare interstitial lung diseases (ILDs) is diverse and complex. Diagnosis and
therapy usually pose challenges. This review describes a selection of rare and ultrarare …
therapy usually pose challenges. This review describes a selection of rare and ultrarare …
Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)
T Geberhiwot, M Wasserstein, S Wanninayake… - Orphanet Journal of …, 2023 - Springer
Abstract Background Acid Sphingomyelinase Deficiency (ASMD) is a rare autosomal
recessive disorder caused by mutations in the SMPD1 gene. This rarity contributes to …
recessive disorder caused by mutations in the SMPD1 gene. This rarity contributes to …
Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature
JB Hennermann, EM Raebel, F Donà… - Orphanet journal of rare …, 2022 - Springer
Background Alpha-mannosidosis is a rare autosomal recessive lysosomal storage disorder
(LSD) caused by reduced activity of alpha-mannosidase. Clinical manifestations include …
(LSD) caused by reduced activity of alpha-mannosidase. Clinical manifestations include …
[HTML][HTML] Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations
A Rossi, S Basilicata, M Borrelli, CR Ferreira… - Molecular Genetics and …, 2023 - Elsevier
At any age, respiratory manifestations are a major cause of increased morbidity and
mortality of inherited metabolic diseases (IMDs). Type and severity are extremely variable …
mortality of inherited metabolic diseases (IMDs). Type and severity are extremely variable …
Acid sphingomyelinase deficiency: sharing experience of disease monitoring and severity in France
W Mauhin, R Borie, F Dalbies, C Douillard… - Journal of Clinical …, 2022 - mdpi.com
Acid sphingomyelinase deficiency (ASMD) is a rare inherited lipid storage disorder caused
by a deficiency in lysosomal enzyme acid sphingomyelinase which results in the …
by a deficiency in lysosomal enzyme acid sphingomyelinase which results in the …
Genetic regulation and targeted reversal of lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
LD Harvey, M Alotaibi, HJJ Kim, YY Tai, Y Tang, W Sun… - bioRxiv, 2024 - biorxiv.org
Vascular inflammation critically regulates endothelial cell (EC) pathophenotypes, particularly
in pulmonary arterial hypertension (PAH). Dysregulation of lysosomal activity and …
in pulmonary arterial hypertension (PAH). Dysregulation of lysosomal activity and …
The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann–Pick Disease: A Comprehensive Review
C Tirelli, O Rondinone, M Italia, S Mira, LA Belmonte… - Biomolecules, 2024 - mdpi.com
Niemann–Pick Disease (NPD) is a rare autosomal recessive disease belonging to
lysosomal storage disorders. Three types of NPD have been described: NPD type A, B, and …
lysosomal storage disorders. Three types of NPD have been described: NPD type A, B, and …
Endolysosomal cation channels and lung disease
Endolysosomal cation channels are emerging as key players of endolysosomal function
such as endolysosomal trafficking, fusion/fission, lysosomal pH regulation, autophagy …
such as endolysosomal trafficking, fusion/fission, lysosomal pH regulation, autophagy …
[PDF][PDF] Niemann-Pick Type B: a rare cause of interstitial lung disease
RS Martins, S Rocha, A Guimas, R Ribeiro - Cureus, 2022 - cureus.com
Niemann-Pick disease (NPD) is a rare lysosomal storage disease (LSD) with multisystemic
involvement. The disease is heterogeneous and classified into three subtypes: type A and B …
involvement. The disease is heterogeneous and classified into three subtypes: type A and B …